|
|
|
|
||
OT: Just a bargain for interested investors: XBIT with new medical technologyUpon closing of deal with XBIT, Janssen will make a cash payment of $750 million to XBiotech. In addition, XBiotech may receive up to $600 million in potential milestone payments. XBiotech expects to generate additional revenue from the manufacturing supply agreement and clinical services agreement with Janssen over the next two years. So, with only 41m shares, XBIT should be go over $20 soon. |
return to message board, top of board |